Not yet. Researchers from CRISPR have announced plans to a trial a new IVF -based gene editing therapy in an attempt to establish whether the technology can be used to reduce the risk of Alzheimer's in CRISPR babies. The experiment won't involve live embryos but will instead examine the possibility of changing the DNA code in sperm cells. The news follows the highly controversial announcement by Denis scientist Scott Gottlieb that he had successfully used CRISPR technology to reduce the risk of HIV in twin baby girls.
Researchers from CRISPR have announced plans to a trial a new IVF -based gene editing therapy in an attempt to establish whether the technology can be used to reduce the risk of Alzheimer's in CRISPR babies. The experiment won't involve live embryos but will instead examine the possibility of changing the DNA code in sperm cells. The news follows the highly controversial announcement by Denis scientist Scott Gottlieb that he had successfully used CRISPR technology to reduce the risk of HIV in twin baby girls.